These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2875728)

  • 1. Verapamil in angina pectoris.
    Kelly DT
    Br J Clin Pharmacol; 1986; 21 Suppl 2(Suppl 2):191S-195S. PubMed ID: 2875728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blocking drugs for chronic, stable angina. Verapamil.
    Kelly DT
    Int J Cardiol; 1982; 2(1):19-22. PubMed ID: 6127322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil in treatment of chronic stable angina.
    Frishman WH; Charlap S
    Arch Intern Med; 1983 Jul; 143(7):1407-15. PubMed ID: 6135403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL; Manyari DE; Kostuk WJ
    Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-entry blockade, beta-adrenergic blockade and the reflex control of circulation.
    Oesterle SN; Schroeder JS
    Circulation; 1982 Apr; 65(4):669-70. PubMed ID: 6120768
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-anginal, electrophysiologic and hemodynamic effects of combined beta-blocker/calcium antagonist therapy.
    Vanhaleweyk GL; Serruys PW; Hugenholtz PG
    Eur Heart J; 1983 Jul; 4 Suppl D():117-28. PubMed ID: 6137370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers and calcium antagonists in angina pectoris. The potential role of combination therapy.
    Dargie HJ
    Drugs; 1988; 35 Suppl 4():44-50. PubMed ID: 2897903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-anginal effects of calcium antagonists and intra-cardiac hemodynamics].
    Zeĭnalov FI; Malov AG; Mazur NA; Sergienko VB; Sumarokov AB; Rubanovich AI
    Kardiologiia; 1991 Jun; 31(6):51-4. PubMed ID: 1656129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm.
    Held C; Hjemdahl P; Rehnqvist N; Wallén NH; Björkander I; Eriksson SV; Forslund L; Wiman B
    Circulation; 1997 May; 95(10):2380-6. PubMed ID: 9170400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with beta-adrenoceptor blockers and calcium antagonists.
    Dargie HJ
    Br J Clin Pharmacol; 1986; 21 Suppl 2(Suppl 2):155S-160S. PubMed ID: 2875727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha- and beta-blockade in angina pectoris.
    Taylor SH
    Drugs; 1984; 28 Suppl 2():69-87. PubMed ID: 6151892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS).
    Forslund L; Hjemdahl P; Held C; Björkander I; Eriksson SV; Brodin U; Rehnqvist N
    Eur Heart J; 2000 Jun; 21(11):901-10. PubMed ID: 10806014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verapamil in the long-term treatment of angina pectoris.
    Raftos J
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():43-9. PubMed ID: 6811176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous verapamil on exercise tolerance and left ventricular function in patients with severe exertional angina pectoris.
    Carlens P
    J Cardiovasc Pharmacol; 1981; 3(1):1-10. PubMed ID: 6160338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of verapamil in patients with angina pectoris after 1 year of continuous, high-dose therapy.
    Weiner DA; McCabe CH; Cutler SS; Creager MA; Ryan TJ; Klein MD
    Am J Cardiol; 1983 May; 51(8):1251-5. PubMed ID: 6342351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is preferable in unstable angina, beta-blockade or calcium-inhibition?
    Hugenholtz PG; Serruys PW; Simoons ML
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():199-209. PubMed ID: 6134510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of propranolol and verapamil on oxygen utilization, acidosis and fatigue during exercise in stable angina pectoris.
    Roubin GS; Sadick NA; Anderson SD; Devenish-Meares S; Harris PJ; Kelly DT
    Am J Cardiol; 1987 Aug; 60(4):249-55. PubMed ID: 3618485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.